Chinese_Academy_of_Medical_Sciences_COVID-19_vaccine

Chinese Academy of Medical Sciences COVID-19 vaccine

Chinese Academy of Medical Sciences COVID-19 vaccine

Vaccine against COVID-19

Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute of Medical Biology, Chinese Academy of Medical Sciences [zh].

Quick Facts Vaccine description, Target ...

Clinical trials

In May 2020, Covidful started phase I/II clinical trial with 942 participants in China.[2]

In January 2021, Covidful started phase III clinical trials with 34,020 from Brazil and Malaysia.[3]

Authorizations

  Full authorization
  Emergency authorization
  Allowed for travel
See also: List of COVID-19 vaccine authorizations § Chinese Academy of Medical Sciences

On 9 June 2021, The vaccine has been approved by the Chinese authorities.[1]

References

  1. [1]
    Liu R, Woo R (9 June 2021). "China builds new plant for IMBCAMS COVID-19 vaccine -state media". Reuters. Retrieved 15 June 2021.
  2. [2]
    Clinical trial number NCT04412538 for "Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19" at ClinicalTrials.gov
  3. [3]
    Clinical trial number NCT04659239 for "The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19" at ClinicalTrials.gov
Scholia has a profile for Chinese Academy of Medical Sciences COVID-19 vaccine (Q106514790).
Stub icon

This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it.

Stub icon

This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it.

Stub icon

This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Chinese_Academy_of_Medical_Sciences_COVID-19_vaccine, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.